Pharmaceutical companies generate vast data during drug development and regulatory processes, making eDiscovery complex due to data volume, sensitivity, and compliance. Efficient eDiscovery solutions are essential to manage legal and regulatory demands, reduce costs, and ensure data accuracy and security.
Overview -
This white paper covers best practices for eDiscovery in the pharmaceutical industry, focusing on challenges posed by the vast volume and sensitivity of electronically stored information (ESI) generated during drug development, clinical trials, and regulatory compliance.
It highlights the importance of efficient data management, the complexities of legal and regulatory requirements, and the use of advanced technologies, such as AI, to streamline discovery, reduce costs, and ensure compliance.
Please see full publication below for more information.
